Cannabis in Germany

Cannabis in Germany

The so-called “traffic-light” coalition is attempting to revolutionise Germany’s drug policy. The current plan to legalise cannabis is, however, a rather cautious approach to that. Yet, the debate has shown how much cannabis is already part of many people’s lives. Although this is a legalisation “light”, as some critics call it, Germany is, step by step, moving away from a purely restrictive drug policy.

Euromonitor International's Cannabis in Germany market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2028 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report??
* Get a detailed picture of the Cannabis market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.